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OBJECTIVES: We compare the optical quality and design characteristic a new low cost solar powered binocular indirect
ophthalmoscope (BIO), Holo, to Keeler BIO.
METHODS: Twenty-four participants each examined 10 simulation eyes using both the Holo and the Keeler BIO with a 30-diopter
condensing lens. Number of Lea symbols printed on the retina of simulation eyes seen and time taken to identify them was
recorded. Stereoacuity of 12 participants was tested while using the BIOs. Using 7-point Likert scale, participants gave feedback on
design characteristic of both BIOs.
RESULTS: There was no statistical difference in number of Lea symbols correctly identified (15.63/20 for Holo vs. 15/20 for
Keeler BIO, p= 0.366, paired t test) or time taken to correctly identify each symbol (Holo 0.39 s faster; 95% confidence interval
−2.24 to 3.03 s, p= 0.763) using each device. 12 out of 12 participants achieved stereoacuity of 60 arcsec using the Holo while
with the Keeler BIO 11 achieved 60 arcsec and one 90 arcsec. There was no statistically significant difference in the scores for
clarity of view, quality of illumination, field of view, binocularity, eye strain and robustness between the two devices. The Holo,
scored higher for ease of use (6.5 vs. 6, p= 0.00488, Wilcoxon signed-rank test), comfort of wear (6 vs. 5, p= 0.000337) and
portability (7 vs. 6, p= 0.000148).
CONCLUSION: The Holo has the potential to be a clinically useful yet affordable diagnostic tool suitable for the first time of
equipping eye care workers in low resource settings with a BIO at volume.
Eye; https://doi.org/10.1038/s41433-021-01901-7
INTRODUCTION
Globally, 553 million people have some degree of visual
impairment with an estimated 43.3 million being blind [1]. Nine
out of ten of those with blindness live in low- and middle- income
countries (LMICs) [1] with 80% being avoidable with early
diagnosis and treatment [2]. Hence, the Lancet Commission on
Technologies for Global Health and WHO both recommend
sustainable and innovative development of frugal diagnostic tools
to meet the needs of users in LMICs [3, 4].
The binocular indirect ophthalmoscope (BIO) is an important
diagnostic tool for assessing posterior segment eye diseases. The
BIO, in contrast to the view achievable with the more commonly
available direct ophthalmoscope, offers a wide stereoscopic view
of the retina, often despite hazy media [5]. Traditional BIOs are,
however, typically expensive, depend on hard to find and costly
consumables, are unnecessarily complex to use and often lack
the durability needed to withstand use in rural settings. As a
consequence they are rarely found outside of major eye units in
financially stretched health care services.
Consequently, a low cost solar powered BIO (Fig. 1a and
Video 1) called the ‘Holo’ has been developed using a frugal
engineering approach [6]. Through use of fixed prism wide-entry
eyepieces and a single light emitting diode (LED) illumination
system manufacturing costs are minimised and simplicity of use
maximised. The Holo is designed to be comfortable to wear with
an adjustable elastic band, weighing 100 grams with charge
lasting for 4 h when using maximum illumination (Video 1).
In this study we compare the optical quality and design
characteristics of the Holo ($75) with a widely available
traditional spectacle mounted device, the Keeler Spectra Iris
Indirect Ophthalmoscope (Keeler BIO - $3203.90) amongst a
range of eye care practitioners.
MATERIALS AND METHODS
University Teaching and Research Ethics Committees of the University of St
Andrews granted approval to undertake the study which followed the
tenets of the Declaration of Helsinki.
Twenty-four participants who used a BIO in their daily work were
recruited (12 consultant ophthalmologists, 10 ophthalmology residents
and 2 hospital optometrists). They examined simulated eyes (SE –
Fig. 1b, c) using both the Holo and the Keeler BIO with a 30-diopter Volk
condensing lens (Fig. 1d). After a 30 min familiarisation session with
the two devices examining training SEs, all participants examined five
pairs of study SEs with both devices randomly assigned to start with
the either the Holo or the Keeler BIO. Two Lea symbols (apple, square,
house or circle) of varying sizes were printed on retinal images at
the back of each SE (Fig. 1b) [7]. The participants had one minute
to attempt to identify the two Lea symbols printed on the fundus of
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each SE. The correct identification and time taken to identify the symbols
was recorded.
Twelve of the participants additionally examined SEs with Frisby-style
stereo plates of two different thicknesses (60 and 90 arcsec) instead of
images of fundi.
After using the two BIOs a 7-point Likert scale was used to rate the
following characteristics: ease of use, quality of illumination, robustness,
portability, comfort of wear, clarity of view, binocularity, field of view and
eye strain.
Participants were finally asked how frequently they used the additional
features of a BIO including: safety filter, cobalt blue filter, red-free filter and
variable aperture using a 5 option response; never and not aware of the
feature, never but aware of the feature, less than 50% of the time, half of
the time or more, and 100% of the time.
Using IBM SPSS Statistics V.26, paired t test was performed for the paired
continuous variables. Wilcoxon signed-rank test was performed for the paired
ordinal variables. All tests were two-tailed with type I error set at α= 0.05 and
it was ensured that data met the particular test’s assumptions.
RESULTS
There was no statistical difference in the diagnostic and optical
performance of the two devices. The number of Lea symbols
correctly identified using either device (15.63/20 (Standard deviation
(SD)= 3.74) for Holo vs. 15/20 (SD= 3.35) for Keeler BIO, p= 0.366,
paired t test) was statistically the same. There was also no difference
in time taken to correctly identify each symbol (Holo 0.39 s faster;
95% confidence interval −2.24 to 3.03 s, p= 0.763, paired t test,
mean time per symbol for Holo= 14.44 s (SD= 6.17) and mean time
per symbol for Keeler= 14.83 s (SD= 5.86)).
There was no statistically significant difference between the
different participants in either the number of symbols seen or time
taken to identify.
12 out of the 12 participants achieved stereoacuity of 60 arcsec
using the Holo while with the Keeler BIO 11 achieved 60 arcsec
and one 90 arcsec.
There was no statistically significant difference in the scores
recorded for clarity of view, quality of illumination, field of view,
binocularity, eye strain and robustness between the two devices.
The Holo however scored statistically significantly higher for ease
of use (6.5 vs. 6, p= 0.00488, Wilcoxon signed-rank test), comfort
of wear (6 vs. 5, p= 0.000337, Wilcoxon signed-rank test) and
portability (7 vs. 6, p= 0.000148, Wilcoxon signed-rank test).
Most additional features of a traditional BIO are used infrequently
with some being rarely used, if at all. The safety filter was almost
never used with 2/3 of participants were unaware of the existence
of the feature. The most commonly used feature was varying
illumination, which was utilised at least half the time by participants.
The rate of usage of different features of traditional BIOs has been
summarised in Table 1.
DISCUSSION
High resource countries make extensive use of widely available
sophisticated and expensive technology while those living in the
world’s poorest countries, where the burden of disease is greatest,
lack access to even the most basic drugs and equipment [3, 4].
We show the Holo to offer users a comparable view of the
posterior segment to that achieved with a more expensive
traditional Keeler BIO. This is evidenced by users of either device
being equally able to accurately identify symbols of varying size
and location printed onto the fundi of SEs. In addition, despite
using a fixed IPD viewing arrangement, objective stereoacuity
achieved with the simplified BIO design was no different from a
device with a variable viewing system.
The equal optical performance of the two devices was further
supported by the participants’ opinions on the design characteristics
where the clarity of view, quality of illumination, field of view,
perception of binocularity, eye strain and robustness of the two
devices were found to be equivalent. Users however favoured the
Holo for ease of use, comfort and portability compared to the Keeler
BIO. However, longer term studies will need to be performed to
confirm these findings hold for sustained use.
We used objective non-clinical symbols in simulated eyes rather
than real pathologies in patients to create an objective assessment
tool that focused on the attributes of the different BIOs rather than
being confounded by varied knowledge and experience of users
as well as the subjectivity of interpreting real clinical signs. Indeed,
there was no difference in performance of the participants despite
their range of clinical experience.
Interestingly most of the additional features of traditional BIOs
that add to the cost, complexity and likelihood for failure were
reported to be infrequently used, if even known about at all. The
most used feature was variable illumination, a feature present on
the Holo.
The ability to bring the viewing and illumination axis closer to
improve the view through small pupils is an optical advantage of
traditional devices. This feature is not present in the Holo as a
fixed viewing system to reduce the number of moving parts is key
to maximising durability and functional longevity. In creating a
frugal and durable device these engineering trade-offs are
unavoidable. To partly overcome this limitation it is possible to
Fig. 1 Holo binocular indirect ophthalmoscope and simulation
eyes. a Frugal ‘Holo’ binocular indirect ophthalmoscope. b Lea
symbols printed on gored fundi. c Hemi-spherical fundi placed in
simulation eyes. d Participant examining pair of simulation study eye.
Table 1. Frequency of additional features of a binocular indirect ophthalmoscope used by the participants in their daily practice.
Features Safety filter Cobalt blue filter Red free filter Varying light aperture Varying illumination
Unaware of this feature 67% 0% 0% 0% 0%
Aware of this feature but never use it 25% 38% 54% 17% 0%
Use it <50% of the time 4% 50% 46% 33% 0%
Use it ≥50% of the time 4% 8% 0% 25% 42%
Use it 100% of the time 0% 4% 0% 25% 58%
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reduce the brightness of the illumination to minimise pupil
constriction.
The light source intensity and spectral spread of the Holo is
consistent with a Class 1 medical device. We are Currently seeking
United Kingdom Conformity Assessed (UKCA) and Conformitè
Europëenne (CE) accreditation for this [8, 9]. In addition, a green
filter cap for the light source is in development to allow
examination of the retinal nerve fibre layer in more detail.
With accreditation and these additional features in place studies in
a clinical setting can be performed to explore the findings from
this initial study involving simulation eyes.
In conclusion, this study demonstrates that the Holo has the
potential to be a clinically useful yet affordable diagnostic tool
suitable for the first time of equipping eye care workers in LMICs
with a BIO at volume. The need to develop frugal technologies
using innovative designs and manufacturing techniques to equip
healthcare workers in low resource setting is more urgent than
ever. The Holo represents such a device that can complement
the many other strategies being established globally to reduce
avoidable blindness [10].
Summary
What was known before
● Binocular indirect ophthalmoscope is an important device in
diagnosing retinal disease.
● Traditional binocular indirect ophthalmoscope is too expensive
to be widely available in low and middle income countries.
What this study adds
● Holo, a frugal binocular indirect ophthalmoscope, offers users
a comparable view of the retina to that achieved with a more
expensive traditional binocular indirect ophthalmoscope.
● Holo can be used to equip eye care workers in low resource
settings with a binocular indirect ophthalmoscope at volume.
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